Target intelligence / Profile preview

Hematopoietic stem cell genome

Molecular classification
Other
01

Overview

The hematopoietic stem cell genome comprises all nuclear genetic material within host HSCs, underpinning vital functions such as self-renewal, multilineage differentiation, and genome maintenance necessary for blood homeostasis throughout life[3][5][6]. It is regulated at multiple molecular levels—including chromatin organization, cis- and trans-regulatory elements, histone modifications, and specific transcription factors—which collectively orchestrate HSC fate and differentiation[1][2][5][6]. Dysfunction or genetic/epigenetic variation in this genome may lead to blood disorders, hematological malignancy, or impaired regenerative capacity[3][5][6]. The entry "Host Hematopoietic Stem Cell Genome" is overbroad and inaccurate as a drug target, as therapies and research typically focus on specific genes, regulatory elements, or pathways within the hematopoietic stem cell population.

Other names
Host HSC genomeHematopoietic stem cell DNAHSC nuclear genome
02

Biological functions

Cell fate specificationSelf-renewalMultilineage differentiationGenome maintenanceRegulation of blood homeostasisCellular metabolismEpigenetic regulation
03

Disease associations

Hematopoietic malignancies (e.g., leukemia)AgingBlood disordersPhenotypic diversity
04

Safety considerations

Genomic instabilityOff-target effects of gene editingRisk of leukemic transformation via acquisition of mutationsAging-related decline in genomic integrity
05

Biomarkers

Genetic variants in cis-regulatory elementsSNPs affecting HSC pool size and functionEpigenetic marks such as DNA methylation and histone modifications

Beyond the preview

Go deeper on Hematopoietic stem cell genome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematopoietic stem cell genome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call